扶脾益肠汤联合扶正和祛邪胶囊对结肠癌术后疗效的影响  被引量:1

Effect of Fupi Yichang Decoction Combined with Fuzheng and Quxie Capsules on Postoperative Curative Effect of Colon Cancer

在线阅读下载全文

作  者:裴晓峰 PEI Xiao-feng(Department of Surgery,Benxi Hospital of Traditional Chinese Medicine,Benxi 117000,China)

机构地区:[1]辽宁省本溪市中医院外科,辽宁本溪117000

出  处:《中国医药指南》2020年第15期190-191,共2页Guide of China Medicine

摘  要:目的探讨了脾益肠汤联合扶正和祛邪胶囊对结肠癌术后恢复的临床效果。方法选取2017年6月至2018年7月在本院接受治疗的结肠癌术后患者72例,按照随机数表法将患者分为对照组和观察组各36例,对照组采取扶脾益肠汤进行术后治疗,观察组应用扶脾益肠汤联合扶正和祛邪胶囊进行术后治疗,对比两组患者治疗效果。结果观察组患者的血清肿瘤标志物评分明显优于对照组,差异有统计学意义(P<0.05),观察组患者的治疗总有效率97.22%高于对照组的83.33%,差异有统计学意义(P<0.05),观察组患者的中医侯正积分明显优于对照组,差异有统计学意义(P<0.05)。结论扶脾益肠汤联合扶正和祛邪胶囊对结肠癌术后疗效显著,可有效改善中医侯正积分,改善预后,值得推广。Objective To investigate the clinical effect of Piyichang Decoction combined with Fuzheng and Quxie Capsules on the recovery of colon cancer after operation.Methods Seventy-eight patients with colon cancer treated in our hospital from June 2017 to July 2018 were selected and divided into control group and observation group according to random number table method.The control group was treated with Fupi Yichang Decoction.The observation group was treated with Fupi Yichang Decoction combined with Fuzheng and Quxie Capsules.The therapeutic effect of the two groups was compared.Results The score of serum tumor markers in the observation group was significantly better than that in the control group(P<0.05).The total effective rate in the observation group was 97.22%higher than 83.33%in the control group(P<0.05).The Hou Zheng score in the observation group was significantly better than that in the control group(P<0.05).Conclusion Fupi Yichang Decoction combined with Fuzheng and Quxie Capsules is effective in improving Hou Zheng integral and prognosis of patients with colon cancer after operation.It is worth popularizing.

关 键 词:扶脾益肠汤 扶正和祛邪胶囊 结肠癌 术后疗效 

分 类 号:R735.35[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象